TD Private Client Wealth’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $326 | Hold |
1
| – | – | ﹤0.01% | 1360 |
|
|
2025
Q1 | $270 | Buy |
+1
| New | +$270 | ﹤0.01% | 1367 |
|
|
2023
Q3 | – | Sell |
-9
| Closed | -$1.71K | – | 1215 |
|
|
2023
Q2 | $1.71K | Hold |
9
| – | – | ﹤0.01% | 1178 |
|
|
2023
Q1 | $1.8K | Hold |
9
| – | – | ﹤0.01% | 1161 |
|
|
2022
Q4 | $2.14K | Hold |
9
| – | – | ﹤0.01% | 1114 |
|
|
2022
Q3 | $1.8K | Hold |
9
| – | – | ﹤0.01% | 1117 |
|
|
2022
Q2 | $1.31K | Hold |
9
| – | – | ﹤0.01% | 1160 |
|
|
2022
Q1 | $1.47K | Sell |
9
-6
| -40% | -$980 | ﹤0.01% | 1188 |
|
|
2021
Q4 | $2.54K | Sell |
15
-18
| -55% | -$3.05K | ﹤0.01% | 996 |
|
|
2021
Q3 | $6.23K | Hold |
33
| – | – | ﹤0.01% | 944 |
|
|
2021
Q2 | $5.59K | Hold |
33
| – | – | ﹤0.01% | 949 |
|
|
2021
Q1 | $4.66K | Hold |
33
| – | – | ﹤0.01% | 934 |
|
|
2020
Q4 | $4.29K | Sell |
33
-45
| -58% | -$5.85K | ﹤0.01% | 903 |
|
|
2020
Q3 | $11.4K | Hold |
78
| – | – | ﹤0.01% | 780 |
|
|
2020
Q2 | $11.6K | Hold |
78
| – | – | ﹤0.01% | 785 |
|
|
2020
Q1 | $8.49K | Buy |
78
+3
| +4% | +$327 | ﹤0.01% | 771 |
|
|
2019
Q4 | $8.64K | Buy |
+75
| New | +$8.64K | ﹤0.01% | 768 |
|